CRESCENDO
Crescendo Biologics Limited
Application Filed: 2021-08-12
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79331946 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Timeline
| 2021-08-12 | Application Filed |
| 2022-01-27 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-01-27 | Status: Live/Pending |
| 2022-01-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Crescendo Biologics Limited |
| Entity Statement | Limited Company |
| Address | Meditrina Building, Babraham Research Campus Cambridge CB223AT GB |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 140302 | Bolts; Fasteners, bolts; Fasteners, nails; Fasteners, screws; Nails (hardware); Nuts (hardware); Rivets; Screws; Tacks, thumb; Thumbtacks |
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 31 |
| U.S. Codes: | 001,046 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Chemicals used in industry and science; chemicals for laboratory research purposes; chemicals for use in medical research; chemicals for use in oncological research; antibodies and antibody fragments for scientific and laboratory use; monoclonal antibodies and antibody fragments for scientific and laboratory use; antibodies and antibody fragments for scientific research purposes; antibody reagents for scientific and laboratory use; antibodies and antibody fragments for use in medical research; antibodies and antibody fragments for use in oncological research; molecules primarily comprised of antibodies and antibody fragments for use in medical research; molecules primarily comprised of antibodies and antibody fragments for use in oncological research; antibodies and antibody fragments for use in the manufacture of therapeutic products |
| GS0401 | Custom manufacture of chemicals, biologicals, antibodies and antibody fragments; services for the custom manufacture of therapies using antibodies and antibody fragments; custom manufacture of antibody and antibody fragments, for others, for use in medical therapies, including in relation to oncology; consultancy, advice and information relating to all of the aforesaid services |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-01-27 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-01-29 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-02-02 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-05-13 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-05-23 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-05-24 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2022-06-16 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-06-16 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2022-07-13 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-08-11 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-08-11 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-08-11 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-08-15 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-08-31 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2022-09-07 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-09-07 | 16 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2022-09-20 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-09-20 | 18 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2022-09-27 | 19 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2022-12-06 | 20 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-12-06 | 21 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-03-06 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2023-03-28 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2023-03-29 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-04-19 | 25 FINO P: |
| RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | 2023-08-19 | 26 RHRD I:Incoming Correspondence |
| LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2023-10-27 | 27 LIMN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 